Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. UMC Utrecht

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

The University Medical Center Utrecht (UMC Utrecht) is one of the largest academic hospitals and research institutions in the Netherlands. Affiliated with Utrecht University, this expansive healthcare hub integrates the main academic hospital, the faculty of Medicine, and the Wilhelmina Children's Hospital under a single framework. Operating as a top-tier regional employer, UMC Utrecht employs roughly 10,000 medical professionals, researchers, and support staff dedicated to highly specialized medical treatments, cutting-edge clinical research, and training the next generation of healthcare providers. The institution delivers advanced tertiary care across critical disciplines including oncology, neurology, cardiology, and rare pediatric diseases, positioning it as a fundamental pillar of medical innovation and patient-centered care in Europe.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. University hospital

Business Subcategory

Source: Human-provided. University hospital
Source: Human-provided. Hospital
Source: Trial-derived.
220Total Trials
Source: Trial-derived.
46Recruiting Trials
Source: Trial-derived.
102Active Trials
Source: Trial-derived.
90Completed Trials
Source: Trial-derived.
294Unique Conditions
Source: Trial-derived.
178Unique Sponsors

Conditions

Source: Trial-derived. Atopic Dermatitis (6)Source: Trial-derived. Cystic Fibrosis (6)Source: Trial-derived. Ulcerative Colitis (6)Source: Trial-derived. Amyotrophic Lateral Sclerosis (5)Source: Trial-derived. Advanced Solid Tumors (4)Source: Trial-derived. Atherosclerotic Cardiovascular Disease (4)Source: Trial-derived. Diabetes Mellitus, Type 2 (4)Source: Trial-derived. Multiple Myeloma (4)

Sponsors

Source: Trial-derived. AbbVie (27)Source: Trial-derived. UMC Utrecht (21)Source: Trial-derived. Amgen (17)Source: Trial-derived. Eli Lilly and Company (16)Source: Trial-derived. Hoffmann-La Roche (14)Source: Trial-derived. Merck Sharp & Dohme LLC (11)Source: Trial-derived. Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (7)Source: Trial-derived. Agios Pharmaceuticals, Inc. (7)

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Overnight or inpatient research stays supported

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits
Source: AI-inferred. Electronic data capture

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. MRI
Source: AI-inferred. Six-minute walk test
Source: AI-inferred. Spirometry
Source: AI-inferred. CT Scan
Source: AI-inferred. Echocardiography
Source: AI-inferred. PET-CT
Source: AI-inferred. Continuous glucose monitoring

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. Pharmacokinetic bioanalysis
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Sequencing / genomics

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling
Source: AI-inferred. Sterile preparation (laminar-flow hood / BSC or cleanroom)

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Endoscopy / colonoscopy
Source: AI-inferred. Bone marrow biopsy
Source: AI-inferred. Radiation therapy
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)
Source: AI-inferred. Blood transfusion service
Source: AI-inferred. Lumbar puncture
Source: AI-inferred. Radiopharmaceutical handling and administration

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Sweat chloride testing
Source: AI-inferred. Bone mineral density measurement
Source: AI-inferred. Donor chimerism testing
Source: AI-inferred. Handheld dynamometry
Source: AI-inferred. Minimal residual disease (MRD) testing
Source: AI-inferred. Ophthalmological examination
Source: AI-inferred. Plasma methylmalonic acid and 2-methylcitric acid quantification
Source: AI-inferred. Allogeneic haematopoietic stem cell transplantation